
    
      Ixabepilone is a FDA approved drug for the treatment of metastatic or locally advanced breast
      cancer after failure of chemotherapy. SBRT is a treatment method to deliver a high dose of
      radiation to the target, utilizing either a single dose or a small number of treatments with
      a high degree of precision within the body. The combination of Ixabepilone with SBRT is not
      an approved treatment at this time.
    
  